NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO
Today is the first day of the subscription period in
Summary of the Rights Issue
- Existing shareholders in the Company receives one (1) subscription right for each existing share in the Company which was held as of the record date on
28 November 2023 . Ten (10) subscription rights entitle the holder to subscribe for eleven (11) new shares. - The subscription price in the Rights Issue is
SEK 0.20 per new share. - The subscription period for the Rights Issue will run from and including
30 November 2023 up to and including14 December 2023 . - Trading in subscription rights will run from and including
20 November 2023 up to and including11 December 2023 . - In order for the subscription rights not to be void, the holder must either sell the subscription rights which are not intended to be used no later than
11 December 2023 , or use the subscription rights to subscribe for new shares no later than14 December 2023 . - Prior to the Rights Issue, the Company has received subscription commitments totaling approximately
SEK 24.9 million , corresponding to approximately 69.9 percent of the Rights Issue. Furthermore, the Company has entered into guarantee commitments totaling approximatelySEK 35.6 million , corresponding to approximately 30.1 percent of the Rights Issue. Through subscription commitments and guarantee commitments, the Rights issue is secured up to 100 percent. Subscription commitments and guarantee commitments are not secured by bank guarantees, escrow accounts, pledges, or similar arrangements.
Prospectus
For complete terms and conditions and information about the Rights Issue, as well as information about the Company, please refer to the EU Growth Prospectus (“Prospectus”) established by the Board of Directors on the occasion of the Rights Issue, and which was published on
Timetable for the Rights Issue
30 November – | Trading in subscription rights |
30 November – | Subscription period |
Trading in paid subscribed shares (Sw. “BTA”) | |
Around | Estimated publication of the outcome in the Rights Issue |
Advisors
For further information, please contact:
Phone: +46 (0)70 575 50 37
Mail: anders.haegerstrand@annexinpharma.com
The information was submitted for publication, through the agency of the contact persons set out above, on
This document has been prepared in a Swedish and English version. In the event of any deviations, the Swedish version shall prevail.
About
The Company is based in
Important Information
The information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade with shares, paid subscribed share, subscription rights or other securities in the Company. No action has been taken, nor will any actions be taken, to permit an offer to the public in any other jurisdiction than
The information in this press release may not be published or distributed, directly or indirectly, within or into
This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 (the “ProspectusRegulation”) and has not been approved by any regulatory authority in any jurisdiction. In any EEA Member State, other than
In the
This press release contains forward-looking statements that reflect the Company’s intentions, beliefs, or current expectations about and targets for the Company’s future results of operations, financial condition, liquidity, performance, prospects, anticipated growth, strategies and opportunities and the markets in which the Company operates. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe”, “expect”, “anticipate”, “intend”, “may”, “plan”, “estimate”, “will”, “should”, “could”, “aim” or “might”, or, in each case, their negative, or similar expressions. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialize or prove to be correct. Because these statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements as a result of many factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this press release are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this press release or any obligation to update or revise the statements in this press release to reflect subsequent events. Undue reliance should not be placed on the forward-looking statements in this press release. The information, opinions and forward-looking statements contained in this press release speak only as at its date and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this press release.
© Modular Finance, source